Skip to content
Saturday, 21 November 2026
Inspire.News

Unveiling truth, one story at a time

250,000 Kenyans screened for diabetes, hypertension in Boehringer programme

250,000 Kenyans screened for diabetes, hypertension in Boehringer programme
Image: Capital FM Kenya

Boehringer Ingelheim says it has screened more than 250,000 Kenyans and placed over 20,000 on treatment for diabetes and hypertension since 2022 through its Access to Healthcare programme targeting underserved communities.

Full story

Continue reading this story on Capital FM Kenya, the publisher that reported it.

Read the full story at Capital FM Kenya ↗

AI tools

Written by AI from the article text. It can make mistakes; check the original story.

Topics in this story

More from National · Kenya

See all